TrialsgrambetaRCTs are beautiful

TARGET (CT-FFR)

2023

On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide Management of Patients with Stable Coronary Artery Disease: the TARGET Randomized Trial

In 1,216 patients with stable coronary disease and an intermediate stenosis on CT angiography, an on-site machine-learning CT-FFR care pathway reduced invasive angiography without obstructive disease or intervention within 90 days compared with standard care.

Result

Proportion of patients undergoing invasive coronary angiography without obstructive CAD, or with obstructive disease not undergoing intervention, within 90 days
Absolute difference
17.9 points
NNT
6

Absolute difference and NNT are derived from the event rates.

Also reported: Invasive angiography in 69.2% vs 79.4%; revascularisation 49.7% (302/608) vs 42.8% (260/608) (P=0.02); 1-year MACE HR 0.88 (95% CI 0.59–1.30); quality of life and symptoms improved similarly.

Original publication
Subtopic
CT & coronary physiology
Design
Multicentre RCT, China (6 centres)
Relevance
Important: one of several pillars.
Source
Yang J, et al. Circulation. 2023;147(18):1369-1381.doi 10.1161/CIRCULATIONAHA.123.063996

Discussion & critique

The first RCT of on-site machine-learning CT-FFR as a care pathway: it met its primary endpoint by cutting non-actionable invasive angiograms, but revascularisation increased overall without any improvement in symptoms, quality of life or 1-year MACE. Both results need saying together. Open-label, a process endpoint, and a cost trend (−4,233 yuan, P=0.07) that did not reach significance; whether the extra revascularisation helped or harmed is unanswered at one year.